Tectonic Therapeutic, Inc.

NASDAQ:TECX

Biotechnology

Healthcare
$21.04 -0.96%

-$0.29 today

Market cap
$411.32M
Beta
1.22
P/E (TTM)
-6.7
EPS (TTM)
-$4.45
52W Low $14.39High $36.03

Volume 0.17M

Average 0.20M

TECX Account Payables

Amounts the company owes suppliers for goods and services received.

Tectonic Therapeutic, Inc.NASDAQ: TECX

Account Payables · Q1 FY2026 · quarter ended Mar 2026

Account payables falls 59.2% from a year ago

Account payables stood at $2.55M at the end of Q1 FY2026, down 59.2% from a year earlier and up 133.7% from the prior quarter. Over 3 fiscal years it compounded at +23.9% a year.

Context

  • Account payables amounted to 1.0% of total assets at the end of Q1 FY2026, down 1.0 pp from a year earlier.
  • Account payables increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether account payables keeps falling in the next quarterly balance sheet after a -59.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.55M+133.7% QoQ
Last fiscal yearDec 2025
$1.09M+12.0% YoY
Year agoMar 2025
$6.25M-59.2% since
Account Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-59.2%——
1 year+12.0%——
3-year CAGR+23.9%——
5-year CAGR——
10-year CAGR——

Account Payables history

USD · from the balance sheet

Latest · FY2025
1.09M USD
Year-over-year change
+12.0%
4-year CAGR
-11.8%

Account Payables vs competitors

How TECX compares with its peers on the latest reported figures

  • TECX's Mar 2026 account payables of $2.55M is the lowest of the 4 companies compared; the peer median is $7.62M.
  • Its year-over-year change of -59.2% is the lowest of 3, against a peer median of +55.3%.
  • Account payables amounts to 1.0% of total assets for TECX, versus a peer median of 1.1%.
TECX Competitors Peer median
Account Payables for TECX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
GPCRStructure Therapeutics Inc.Jun 2026$11.13M +23.8%+32.1%0.8%
GENBGenerate Biomedicines, Inc.Mar 2026$7.62M ——1.2%
SEPNSepterna, Inc.Sep 2026$6.96M +86.7%+49.6%1.1%
TECXTectonic Therapeutic, Inc.Mar 2026$2.55M -59.2%+23.9%1.0%
Peer median (excluding TECX) $7.62M+55.3%+40.9%1.1%

Competitors are the stored peer set for TECX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents28.06M35.97M28.77M141.24M253.8M
Short-term Investments00000
Net Receivables00000
Inventory00000
Other Current Assets557K1.08M2.12M5.62M3.56M
Total Current Assets28.62M37.04M30.88M146.86M257.36M
Property, Plant & Equipment (Net)3.66M9.55M7.23M5.31M2.55M
Goodwill00000
Intangible Assets00000
Long-term Investments000587K0
Tax Assets00000
Other Non-current Assets599K613K1.29M156K1.13M
Total Non-current Assets4.26M10.17M8.52M6.05M3.68M
Total Assets32.88M47.21M39.4M152.91M261.04M
Account Payables1.81M574K409K976K1.09M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities1.76M2.66M33.37M3.59M4.11M
Total Current Liabilities4.12M7.84M40.89M11.61M9.67M
Long-term Debt000043K
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities43.02M80.68M80.63M00
Total Non-current Liabilities43.72M85.03M83.15M519K43K
Total Liabilities47.84M92.86M124.04M12.13M9.71M
Common Stock0002K2K
Retained Earnings(15.6M)(47.78M)(90.6M)(148.59M)(222.74M)
Accumulated OCI00(11K)9K(96K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity(14.96M)(45.65M)(84.64M)140.78M251.33M
Total Debt1.06M5.79M4.34M3.3M1.28M
Net Debt(27.01M)(30.17M)(24.43M)(137.94M)(252.52M)

Tectonic Therapeutic, Inc.

NASDAQ:TECX

Intrinsic Alpha fair value

Locked

Current Price

$21.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.